Scott Dunseth Myers

Insider Reports History

Location
San Diego, CA
Signature
Scott Dunseth Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Dunseth Myers:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Common Stock 259,500 $5,449,500 $21.00 12 Apr 2023 Direct
Zentalis Pharmaceuticals, Inc. Director Common Stock 338,795 $437,045 $1.29 17 Jun 2025 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 $64,400 $1.40 11 Mar 2024 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock 0 $0 $15.72 10 Feb 2026 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 $0 $23.00 11 Mar 2024 Direct
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Stock Option (Right to Buy) 1,000,000 06 Feb 2023 Direct
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.7900 13 Nov 2023 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock - Restricted Stock Units 0 10 Feb 2026 Direct
DYNAVAX TECHNOLOGIES CORP Director Stock Option (Right to Buy) 0 10 Feb 2026 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by Scott Dunseth Myers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DVAX DYNAVAX TECHNOLOGIES CORP 10 Feb 2026 7 $0 4 Director 10 Feb 2026, 16:15
DVAX DYNAVAX TECHNOLOGIES CORP 22 Aug 2025 1 +$41,116 4 Director 25 Aug 2025, 08:50
ZNTL Zentalis Pharmaceuticals, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:12
DVAX DYNAVAX TECHNOLOGIES CORP 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 17:51
ZNTL Zentalis Pharmaceuticals, Inc. 30 Apr 2025 1 +$29,373 4 Director 30 Apr 2025, 17:07
ZNTL Zentalis Pharmaceuticals, Inc. 13 Nov 2024 1 $0 4 Director 13 Nov 2024, 17:46
ZNTL Zentalis Pharmaceuticals, Inc. 13 Nov 2024 0 $0 3 Director 13 Nov 2024, 17:44
DVAX DYNAVAX TECHNOLOGIES CORP 23 May 2024 2 $0 4 Director 28 May 2024, 20:32
/report/000095017024029443-myers-scott-dunseth-2024-03-11 Harpoon Therapeutics, Inc. 11 Mar 2024 3 $0 4 Director 11 Mar 2024, 17:24
/report/000095017024000962-myers-scott-dunseth-2024-01-01 Harpoon Therapeutics, Inc. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 16:30
/report/000120919123056797-myers-scott-dunseth-2023-11-27 Harpoon Therapeutics, Inc. 27 Nov 2023 1 $0 4 Director 28 Nov 2023, 16:26
RNAC Cartesian Therapeutics, Inc. 13 Nov 2023 5 -$81,375 4 Director 15 Nov 2023, 17:16
/report/000120919123051150-myers-scott-dunseth-2023-10-01 Harpoon Therapeutics, Inc. 01 Oct 2023 1 $0 4 Director 02 Oct 2023, 17:36
/report/000120919123041668-myers-scott-dunseth-2023-07-01 Harpoon Therapeutics, Inc. 01 Jul 2023 1 $0 4 Director 06 Jul 2023, 18:34
/report/000120919123039415-myers-scott-dunseth-2023-06-22 Harpoon Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:36
DVAX DYNAVAX TECHNOLOGIES CORP 26 May 2023 2 $0 4 Director 31 May 2023, 17:35
VRDN Viridian Therapeutics, Inc.\DE 12 Apr 2023 1 +$101,479 4 Chief Executive Officer, Director 12 Apr 2023, 19:05
/report/000120919123022805-myers-scott-dunseth-2023-04-01 Harpoon Therapeutics, Inc. 01 Apr 2023 1 $0 4 Director 04 Apr 2023, 17:06
VRDN Viridian Therapeutics, Inc.\DE 13 Mar 2023 1 +$160,324 4 Chief Executive Officer, Director 13 Mar 2023, 16:06
VRDN Viridian Therapeutics, Inc.\DE 06 Feb 2023 2 $0 4 Chief Executive Officer, Director 07 Feb 2023, 17:55
VRDN Viridian Therapeutics, Inc.\DE 06 Feb 2023 0 $0 3 Chief Executive Officer, Director 07 Feb 2023, 17:45
RNAC SELECTA BIOSCIENCES INC 02 Jan 2023 1 $0 4 Director 04 Jan 2023, 16:06
/report/000120919122039327-myers-scott-dunseth-2022-06-22 Harpoon Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 18:48
DVAX DYNAVAX TECHNOLOGIES CORP 26 May 2022 2 $0 4 Director 27 May 2022, 17:01
RNAC SELECTA BIOSCIENCES INC 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 15:34
/report/000110465921141750-myers-scott-dunseth-2021-11-17 Trillium Therapeutics Inc. 17 Nov 2021 1 $0 4 Director 19 Nov 2021, 12:33
/report/000120919121061631-myers-scott-dunseth-2021-10-25 Harpoon Therapeutics, Inc. 25 Oct 2021 1 $0 4 Director 26 Oct 2021, 16:22
DVAX DYNAVAX TECHNOLOGIES CORP 19 Oct 2021 2 $0 4 Director 21 Oct 2021, 17:04
DVAX DYNAVAX TECHNOLOGIES CORP 19 Oct 2021 0 $0 3 Director 21 Oct 2021, 17:03
/report/000120919121032960-myers-scott-dunseth-2021-05-04-restatement Harpoon Therapeutics, Inc. 04 May 2021 1 $0 4/A Director 14 May 2021, 20:03